|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
Sec Filings Insider Trading - Avalon Pharmaceuticals Inc (AVRX)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |
Avalon Pharmaceuticals Inc: Insider Trading and Stock Options
Common stock purchase or sale:
| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2009-05-28 Sale |
2009-06-01 1:01 pm | AVALON PHARMACEUTICALS INC | AVRX | LORIMIER BRADLEY G (Director) | 8,880 | $0 | $0 | 0 (Direct) | View |
| 2009-05-28 Sale | 2009-06-01 1:00 pm |
AVALON PHARMACEUTICALS INC | AVRX | Hamilton J Michael (Chief Medical Officer) | 2,700 | $0 | $0 | 0 (Indirect) |
View |
| 2009-05-28 Sale | 2009-06-01 12:59 pm | AVALON PHARMACEUTICALS INC | AVRX | Carter Kenneth C (President and CEO Director) | 27,625 | $0 | $0 | 0 (Direct Indirect) | View |
| 2008-01-17 Sale(A) |
2008-01-25 1:25 pm |
AVALON PHARMACEUTICALS INC | AVRX | Carter Kenneth C (President and CEO Director) | 1,400 | $2.65 | $3,710 | 20,443 (Direct) | View |
| 2008-01-23 Purchase | 2008-01-23 8:41 pm |
AVALON PHARMACEUTICALS INC | AVRX | Carter Kenneth C (President and CEO Director) | 4,832 | $2.584 | $12,485 | 23,875 (Direct) |
View |
| 2008-01-17 Sale |
2008-01-23 8:41 pm | AVALON PHARMACEUTICALS INC | AVRX | Carter Kenneth C (President and CEO Director) | 2,032 | $2.532 | $5,145 | 21,843 (Direct) |
View |
| 2005-10-04 Purchase |
2005-10-18 3:57 pm | AVALON PHARMACEUTICALS INC | AVRX | EuclidSR Biotechnology Partners, L.P. EuclidSR Partners, L.P. (Director) | 203,900 | $10.5 | $2,140,950 | 203,900 (Direct) |
View |
| 2005-10-04 Purchase | 2005-10-06 6:16 pm | AVALON PHARMACEUTICALS INC | AVRX | OXFORD BIOSCIENCE PARTNERS III LP Oxford Bioscience Partners (Bermuda) III Limtied Partnership Oxford Bioscience Partners (Adjunct) III L.P. mRNA Fund L.P. OBP Management III L.P. OBP Management (Bermuda) III Limited Partnership mRNA Partners L.P. BARNES JEFFREY T FLEMING JONATHAN WALTON ALAN G (10% owner) | 181,400 | $10.5 | $1,904,700 | 7,961 (Direct Indirect) |
View |
| 2005-10-04 Purchase | 2005-10-06 5:04 pm | AVALON PHARMACEUTICALS INC | AVRX | GIMV NV ADVIESBEHEER GIMV LIFE SCIENCES NV (10% owner) | 181,400 | $10.5 | $1,904,700 | 181,400 (Direct) | View |
(A) Indicate amendment filing.
Other transactions:
| Transaction & Date |
Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price | Total Amount |
Shares Ownership |
Filing |
| 2008-04-01 Option Award |
2008-04-02 5:15 pm | AVALON PHARMACEUTICALS INC | AVRX | ROYSTON IVOR (Director) | 3,528 | $2.48 | $8,749 | 3,528 (Direct) |
View |
| 2008-01-02 Option Award |
2008-01-04 4:46 pm | AVALON PHARMACEUTICALS INC | AVRX | WALTON ALAN G (Director) | 816 | $3.32 | $2,709 | 22,796 (Direct) |
View |
| 2008-01-02 Option Award |
2008-01-04 1:32 pm | AVALON PHARMACEUTICALS INC | AVRX | ROYSTON IVOR (Director) | 2,635 | $3.32 | $8,748 | 2,635 (Direct) | View |
| 2007-10-01 Option Award | 2007-10-02 7:38 pm |
AVALON PHARMACEUTICALS INC | AVRX | WALTON ALAN G (Director) | 1,477 | $5.5 | $8,124 | 21,980 (Direct) | View |
| 2007-10-01 Option Award |
2007-10-02 4:19 pm |
AVALON PHARMACEUTICALS INC | AVRX | ROYSTON IVOR (Director) | 1,591 | $5.5 | $8,750 | 1,591 (Direct) | View |
| 2007-07-02 Option Award |
2007-07-05 3:19 pm | AVALON PHARMACEUTICALS INC | AVRX | WALTON ALAN G (Director) | 3,243 | $4.24 | $13,750 | 20,503 (Direct) |
View |
| 2007-07-02 Option Award | 2007-07-05 09:53 am |
AVALON PHARMACEUTICALS INC | AVRX | Whitaker Raymond J (Director) | 1,658 | $4.24 | $7,030 | 1,658 (Direct) |
View |
| 2007-07-02 Option Award | 2007-07-05 09:52 am | AVALON PHARMACEUTICALS INC | AVRX | ROYSTON IVOR (Director) | 1,931 | $4.24 | $8,187 | 1,931 (Direct) |
View |
| 2005-10-04 Purchase | 2005-10-18 3:57 pm | AVALON PHARMACEUTICALS INC | AVRX | EuclidSR Biotechnology Partners, L.P. EuclidSR Partners, L.P. (Director) | 553,238 | $1.01 | $558,999 | 757,138 (Direct) | View |
| 2005-10-04 Purchase |
2005-10-06 6:16 pm |
AVALON PHARMACEUTICALS INC | AVRX | OXFORD BIOSCIENCE PARTNERS III LP Oxford Bioscience Partners (Bermuda) III Limtied Partnership Oxford Bioscience Partners (Adjunct) III L.P. mRNA Fund L.P. OBP Management III L.P. OBP Management (Bermuda) III Limited Partnership mRNA Partners L.P. BARNES JEFFREY T FLEMING JONATHAN WALTON ALAN G (10% owner) | 572,239 | $0 | $0 | 6,244 (Direct Indirect) |
View |
| 2005-10-04 Purchase | 2005-10-06 5:04 pm | AVALON PHARMACEUTICALS INC | AVRX | GIMV NV ADVIESBEHEER GIMV LIFE SCIENCES NV (10% owner) | 710,207 | $1.213 | $861,368 | 891,607 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction & Date | Reported Date | Exercisable Expiration | Company | Symbol | Insider Relationship | Shares Traded | Conversion Price | Shares Ownership | Filing |
| 2008-08-22 Option Award |
2008-08-26 11:02 am | N/A N/A | AVALON PHARMACEUTICALS INC | AVRX | WINZER C ERIC (EVP & Chief Financial Officer) | 150,000 | $0.8 | 150,000 (Direct) |
View |
| 2008-08-22 Option Award | 2008-08-26 10:57 am |
N/A N/A |
AVALON PHARMACEUTICALS INC | AVRX | Horrigan Stephen K (VP of Research) | 50,000 | $0.8 | 50,000 (Direct) |
View |
| 2008-08-22 Option Award | 2008-08-26 10:28 am |
N/A N/A | AVALON PHARMACEUTICALS INC | AVRX | Carter Kenneth C (President and CEO Director) | 200,000 | $0.8 | 200,000 (Direct) | View |
| 2008-06-04 Option Award | 2008-06-30 4:58 pm |
N/A 2018-06-04 |
AVALON PHARMACEUTICALS INC | AVRX | KABAKOFF DAVID S (Director) | 2,500 | $1.65 | 2,500 (Direct) | View |
| 2008-06-04 Option Award |
2008-06-30 4:56 pm |
N/A 2018-06-04 | AVALON PHARMACEUTICALS INC | AVRX | Kurman Michael R (Director) | 2,500 | $1.65 | 2,500 (Direct) |
View |
| 2008-06-04 Option Award |
2008-06-30 4:55 pm |
N/A 2018-06-04 |
AVALON PHARMACEUTICALS INC | AVRX | WASHECKA WILLIAM H (Director) | 2,500 | $1.65 | 2,500 (Direct) | View |
| 2008-06-04 Option Award |
2008-06-30 4:54 pm | N/A 2018-06-04 |
AVALON PHARMACEUTICALS INC | AVRX | LORIMIER BRADLEY G (Director) | 6,700 | $1.65 | 2,500 (Direct) | View |
| 2008-06-04 Option Award | 2008-06-30 4:53 pm |
N/A 2018-06-04 | AVALON PHARMACEUTICALS INC | AVRX | Frost Philip (Director) | 2,500 | $1.65 | 2,500 (Direct) |
View |
| 2008-03-14 Option Award | 2008-03-17 3:58 pm |
N/A N/A | AVALON PHARMACEUTICALS INC | AVRX | Frost Philip (Director) | 10,000 | $1.98 | 10,000 (Direct) | View |
| 2008-01-25 Option Award |
2008-01-28 12:00 pm |
N/A N/A |
AVALON PHARMACEUTICALS INC | AVRX | Farmer Glen A (Principal Accounting Officer) | 7,600 | $2.38 | 23,350 (Direct) |
View |
| 2008-01-02 Option Award |
2008-01-04 1:34 pm | N/A 2018-01-02 | AVALON PHARMACEUTICALS INC | AVRX | SCOTT WILLIAM A (Director) | 500 | $3.32 | 500 (Direct) |
View |
| 2007-10-10 Option Award |
2007-10-11 11:59 am |
N/A N/A | AVALON PHARMACEUTICALS INC | AVRX | LORIMIER BRADLEY G (Director) | 6,000 | $5.68 | 6,000 (Direct) | View |
| 2007-07-02 Option Award | 2007-07-05 09:54 am | N/A N/A | AVALON PHARMACEUTICALS INC | AVRX | WINZER C ERIC (EVP & Chief Financial Officer) | 120,000 | $4.24 | 120,000 (Direct) | View |
| 2007-06-07 Option Award | 2007-06-26 3:28 pm | N/A 2017-06-07 | AVALON PHARMACEUTICALS INC | AVRX | LORIMIER BRADLEY G (Director) | 5,686 | $5.06 | 5,686 (Direct) |
View |
| 2007-06-07 Option Award | 2007-06-25 09:41 am | N/A 2012-06-07 |
AVALON PHARMACEUTICALS INC | AVRX | WALTON ALAN G (Director) | 1,486 | $5.06 | 1,486 (Direct) | View |
| 2007-06-07 Option Award |
2007-06-22 4:31 pm | N/A 2017-06-07 |
AVALON PHARMACEUTICALS INC | AVRX | WASHECKA WILLIAM H (Director) | 1,486 | $5.06 | 1,486 (Direct) | View |
| 2007-06-07 Option Award | 2007-06-22 4:31 pm | N/A 2017-06-07 |
AVALON PHARMACEUTICALS INC | AVRX | SCOTT WILLIAM A (Director) | 1,486 | $5.06 | 1,486 (Direct) | View |
| 2006-12-06 Option Award | 2006-12-08 4:39 pm | N/A N/A | AVALON PHARMACEUTICALS INC | AVRX | Lessing Gary (Chief Financial Officer) | 112,500 | $3.8 | 298,674 (Direct) | View |
| 2006-12-06 Option Award |
2006-12-08 4:37 pm |
N/A N/A |
AVALON PHARMACEUTICALS INC | AVRX | Bol David K (VP Pharmaceutical Development) | 55,000 | $3.8 | 98,917 (Direct) |
View |
| 2006-12-06 Option Award |
2006-12-08 4:35 pm |
N/A N/A |
AVALON PHARMACEUTICALS INC | AVRX | David Thomas G (General Counsel & Sr VP Oper.) | 40,500 | $3.8 | 133,587 (Direct) | View |
| 2006-09-21 Option Award |
2006-09-25 08:41 am | N/A N/A |
AVALON PHARMACEUTICALS INC | AVRX | Muth David (EVP & Chief Business Officer) | 120,000 | $2.62 | 120,000 (Direct) | View |
| 2005-11-30 Option Award |
2005-12-02 11:45 am |
N/A N/A |
AVALON PHARMACEUTICALS INC | AVRX | Meade James H (VP of Business Development) | 18,724 | $5.5 | 18,724 (Direct) |
View |
| 2005-10-26 Option Award | 2005-10-28 1:03 pm | 2006-04-26 N/A |
AVALON PHARMACEUTICALS INC | AVRX | Beneden Patrick Van (Director 10% owner) | 2,751 | $6 | 2,751 (Direct) | View |
| 2005-10-26 Option Award |
2005-10-28 1:03 pm |
N/A N/A |
AVALON PHARMACEUTICALS INC | AVRX | Beneden Patrick Van (Director 10% owner) | 10,000 | $6 | 10,000 (Direct) |
View |
| 2005-10-26 Option Award | 2005-10-28 12:22 pm | 2006-04-26 N/A | AVALON PHARMACEUTICALS INC | AVRX | Young Paul E (Vice President of Research) | 22,917 | $6 | 22,917 (Direct) | View |
| 2005-10-04 Purchase | 2005-10-18 3:57 pm | N/A N/A | AVALON PHARMACEUTICALS INC | AVRX | EuclidSR Biotechnology Partners, L.P. EuclidSR Partners, L.P. (Director) | 2,267,831 | $0 | 0 (Direct) | View |
| 2005-10-04 Purchase | 2005-10-18 3:57 pm |
N/A 2006-01-01 | AVALON PHARMACEUTICALS INC | AVRX | EuclidSR Biotechnology Partners, L.P. EuclidSR Partners, L.P. (Director) | 0 | $10.5 | 0 (Direct) | View |
| 2005-10-04 Purchase | 2005-10-06 6:16 pm | N/A N/A | AVALON PHARMACEUTICALS INC | AVRX | OXFORD BIOSCIENCE PARTNERS III LP Oxford Bioscience Partners (Bermuda) III Limtied Partnership Oxford Bioscience Partners (Adjunct) III L.P. mRNA Fund L.P. OBP Management III L.P. OBP Management (Bermuda) III Limited Partnership mRNA Partners L.P. BARNES JEFFREY T FLEMING JONATHAN WALTON ALAN G (10% owner) | 150,257 | $0 | 0 (Direct) | View |
| 2005-10-04 Purchase |
2005-10-06 6:16 pm | N/A N/A | AVALON PHARMACEUTICALS INC | AVRX | OXFORD BIOSCIENCE PARTNERS III LP Oxford Bioscience Partners (Bermuda) III Limtied Partnership Oxford Bioscience Partners (Adjunct) III L.P. mRNA Fund L.P. OBP Management III L.P. OBP Management (Bermuda) III Limited Partnership mRNA Partners L.P. BARNES JEFFREY T FLEMING JONATHAN WALTON ALAN G (10% owner) | 253,061 | $0 | 0 (Direct) |
View |
| 2005-10-04 Purchase |
2005-10-06 6:16 pm | N/A N/A |
AVALON PHARMACEUTICALS INC | AVRX | OXFORD BIOSCIENCE PARTNERS III LP Oxford Bioscience Partners (Bermuda) III Limtied Partnership Oxford Bioscience Partners (Adjunct) III L.P. mRNA Fund L.P. OBP Management III L.P. OBP Management (Bermuda) III Limited Partnership mRNA Partners L.P. BARNES JEFFREY T FLEMING JONATHAN WALTON ALAN G (10% owner) | 54,628 | $0 | 0 (Direct) |
View |
| 2005-10-04 Purchase |
2005-10-06 6:16 pm |
N/A N/A |
AVALON PHARMACEUTICALS INC | AVRX | OXFORD BIOSCIENCE PARTNERS III LP Oxford Bioscience Partners (Bermuda) III Limtied Partnership Oxford Bioscience Partners (Adjunct) III L.P. mRNA Fund L.P. OBP Management III L.P. OBP Management (Bermuda) III Limited Partnership mRNA Partners L.P. BARNES JEFFREY T FLEMING JONATHAN WALTON ALAN G (10% owner) | 21,415 | $0 | 0 (Indirect) | View |
| 2005-10-04 Purchase |
2005-10-06 6:16 pm |
N/A N/A |
AVALON PHARMACEUTICALS INC | AVRX | OXFORD BIOSCIENCE PARTNERS III LP Oxford Bioscience Partners (Bermuda) III Limtied Partnership Oxford Bioscience Partners (Adjunct) III L.P. mRNA Fund L.P. OBP Management III L.P. OBP Management (Bermuda) III Limited Partnership mRNA Partners L.P. BARNES JEFFREY T FLEMING JONATHAN WALTON ALAN G (10% owner) | 36,066 | $0 | 0 (Indirect) | View |
| 2005-10-04 Purchase | 2005-10-06 6:16 pm | N/A N/A |
AVALON PHARMACEUTICALS INC | AVRX | OXFORD BIOSCIENCE PARTNERS III LP Oxford Bioscience Partners (Bermuda) III Limtied Partnership Oxford Bioscience Partners (Adjunct) III L.P. mRNA Fund L.P. OBP Management III L.P. OBP Management (Bermuda) III Limited Partnership mRNA Partners L.P. BARNES JEFFREY T FLEMING JONATHAN WALTON ALAN G (10% owner) | 7,786 | $0 | 0 (Indirect) |
View |
| 2005-10-04 Purchase |
2005-10-06 6:16 pm | N/A N/A | AVALON PHARMACEUTICALS INC | AVRX | OXFORD BIOSCIENCE PARTNERS III LP Oxford Bioscience Partners (Bermuda) III Limtied Partnership Oxford Bioscience Partners (Adjunct) III L.P. mRNA Fund L.P. OBP Management III L.P. OBP Management (Bermuda) III Limited Partnership mRNA Partners L.P. BARNES JEFFREY T FLEMING JONATHAN WALTON ALAN G (10% owner) | 14,062 | $0 | 0 (Indirect) | View |
| 2005-10-04 Purchase | 2005-10-06 6:16 pm |
N/A N/A | AVALON PHARMACEUTICALS INC | AVRX | OXFORD BIOSCIENCE PARTNERS III LP Oxford Bioscience Partners (Bermuda) III Limtied Partnership Oxford Bioscience Partners (Adjunct) III L.P. mRNA Fund L.P. OBP Management III L.P. OBP Management (Bermuda) III Limited Partnership mRNA Partners L.P. BARNES JEFFREY T FLEMING JONATHAN WALTON ALAN G (10% owner) | 23,686 | $0 | 0 (Indirect) |
View |
| 2005-10-04 Purchase | 2005-10-06 6:16 pm |
N/A N/A | AVALON PHARMACEUTICALS INC | AVRX | OXFORD BIOSCIENCE PARTNERS III LP Oxford Bioscience Partners (Bermuda) III Limtied Partnership Oxford Bioscience Partners (Adjunct) III L.P. mRNA Fund L.P. OBP Management III L.P. OBP Management (Bermuda) III Limited Partnership mRNA Partners L.P. BARNES JEFFREY T FLEMING JONATHAN WALTON ALAN G (10% owner) | 5,858 | $0 | 0 (Indirect) |
View |
| 2005-10-04 Purchase | 2005-10-06 6:16 pm |
N/A N/A | AVALON PHARMACEUTICALS INC | AVRX | OXFORD BIOSCIENCE PARTNERS III LP Oxford Bioscience Partners (Bermuda) III Limtied Partnership Oxford Bioscience Partners (Adjunct) III L.P. mRNA Fund L.P. OBP Management III L.P. OBP Management (Bermuda) III Limited Partnership mRNA Partners L.P. BARNES JEFFREY T FLEMING JONATHAN WALTON ALAN G (10% owner) | 1,766 | $0 | 0 (Indirect) |
View |
| 2005-10-04 Purchase | 2005-10-06 6:16 pm |
N/A N/A |
AVALON PHARMACEUTICALS INC | AVRX | OXFORD BIOSCIENCE PARTNERS III LP Oxford Bioscience Partners (Bermuda) III Limtied Partnership Oxford Bioscience Partners (Adjunct) III L.P. mRNA Fund L.P. OBP Management III L.P. OBP Management (Bermuda) III Limited Partnership mRNA Partners L.P. BARNES JEFFREY T FLEMING JONATHAN WALTON ALAN G (10% owner) | 3,005 | $0 | 0 (Indirect) |
View |
| 2005-10-04 Purchase | 2005-10-06 6:16 pm |
N/A N/A | AVALON PHARMACEUTICALS INC | AVRX | OXFORD BIOSCIENCE PARTNERS III LP Oxford Bioscience Partners (Bermuda) III Limtied Partnership Oxford Bioscience Partners (Adjunct) III L.P. mRNA Fund L.P. OBP Management III L.P. OBP Management (Bermuda) III Limited Partnership mRNA Partners L.P. BARNES JEFFREY T FLEMING JONATHAN WALTON ALAN G (10% owner) | 649 | $0 | 0 (Indirect) |
View |
| 2005-10-04 Purchase | 2005-10-06 5:04 pm | N/A N/A |
AVALON PHARMACEUTICALS INC | AVRX | GIMV NV ADVIESBEHEER GIMV LIFE SCIENCES NV (10% owner) | 1,500,000 | $0 | 0 (Direct) |
View |
| 2005-10-04 Purchase | 2005-10-06 5:04 pm | N/A N/A |
AVALON PHARMACEUTICALS INC | AVRX | GIMV NV ADVIESBEHEER GIMV LIFE SCIENCES NV (10% owner) | 1,698,927 | $0 | 0 (Direct) | View |
| 2005-10-04 Purchase |
2005-10-06 5:04 pm | N/A 2006-01-01 |
AVALON PHARMACEUTICALS INC | AVRX | GIMV NV ADVIESBEHEER GIMV LIFE SCIENCES NV (10% owner) | 0 | $10.5 | 0 (Direct) |
View |
| 2005-10-04 Purchase |
2005-10-06 5:04 pm |
N/A N/A | AVALON PHARMACEUTICALS INC | AVRX | GIMV NV ADVIESBEHEER GIMV LIFE SCIENCES NV (10% owner) | 299,810 | $0 | 0 (Direct) |
View |
| 2005-10-04 Purchase | 2005-10-06 5:04 pm | N/A 2006-01-01 |
AVALON PHARMACEUTICALS INC | AVRX | GIMV NV ADVIESBEHEER GIMV LIFE SCIENCES NV (10% owner) | 0 | $10.5 | 0 (Direct) | View |
|
© 2005-2009 SecForm4.Com All rights reserved. Archives: 2009 2008 2007 2006 2005 2004 ... Sat, 21 Nov 2009 15:12:51 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |